Is Catalyst Pharmaceuticals, Inc. (CPRX) a Buy, Sell, or Hold?
NASDAQ : CPRX
Catalyst Pharmaceuticals, Inc. — Earnings Estimates
$31.49 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 3.01M
- Market Capitalization
- $3.85B
- P/E Ratio
- 17.49
- Dividend Yield
- 0.00%
- Price Target
- $31.75
- Year High
- $32.56
- Year Low
- $19.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.10
Annual earnings financials
CPRX financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
CPRX Estimated and Actual Revenue by Quarter
CPRX Estimated and Actual EPS by Quarter
CPRX Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 1 | 79.52M | 81.98M | 80.94M | 71.37M | 73.58M | 72.65M |
| 2027-09-30 | 2 | 78.27M | 80.7M | 79.68M | 70.25M | 72.42M | 71.51M |
| 2027-06-30 | 2 | 77.18M | 79.57M | 78.56M | 69.27M | 71.41M | 70.51M |
| 2027-03-31 | 1 | 75.7M | 78.04M | 77.06M | 67.94M | 70.05M | 69.16M |
| 2026-12-31 | 2 | 74.07M | 76.36M | 75.39M | 66.48M | 68.53M | 67.67M |
| 2026-09-30 | 3 | 71.96M | 73.42M | 72.85M | 64.58M | 65.9M | 65.38M |
CPRX Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 1 | 73.16M | 76.12M | 74.87M | 58.08M | 59.88M | 59.12M |
| 2027-09-30 | 2 | 70.68M | 73.54M | 72.33M | 57.17M | 58.94M | 58.2M |
| 2027-06-30 | 2 | 68.2M | 70.96M | 69.8M | 56.37M | 58.12M | 57.38M |
| 2027-03-31 | 1 | 69.44M | 72.25M | 71.07M | 55.3M | 57.01M | 56.29M |
| 2026-12-31 | 2 | 59.52M | 61.93M | 60.91M | 54.1M | 55.78M | 55.07M |
| 2026-09-30 | 3 | 56.68M | 65.99M | 61.76M | 52.56M | 53.63M | 53.21M |
CPRX Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-31 | 1 | 176.53M | 182M | 179.7M | 1 | 0.57651 | 0.59982 | 0.59 |
| 2027-09-30 | 2 | 173.77M | 179.15M | 176.89M | 1 | 0.55696 | 0.57948 | 0.57 |
| 2027-06-30 | 2 | 171.34M | 176.64M | 174.41M | 1 | 0.53742 | 0.55915 | 0.55 |
| 2027-03-31 | 1 | 168.06M | 173.26M | 171.07M | 1 | 0.54719 | 0.56932 | 0.56 |
| 2026-12-31 | 2 | 164.43M | 169.52M | 167.38M | 1 | 0.46902 | 0.48799 | 0.48 |
| 2026-09-30 | 3 | 159.75M | 163.01M | 161.73M | 1 | 0.44667 | 0.52 | 0.48667 |